Get the Stockscreener App
49.86
0.95%
0.47
Anbio Biotechnology stock is traded at $49.86, with a volume of 87,453.
It is up +0.95% in the last 24 hours and up +24.71% over the past month.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
See More
Previous Close:
$49.39
Open:
$49.2
24h Volume:
87,453
Relative Volume:
0.69
Market Cap:
$2.19B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.06%
1M Performance:
+24.71%
6M Performance:
+764.12%
1Y Performance:
+0.00%
1-Day Range:
$47.41
$52.93
1-Week Range:
$47.41
$54.95
52-Week Range:
$5.60
$55.65
Anbio Biotechnology Stock (NNNN) Company Profile
Name
Anbio Biotechnology
Sector
Industry
Phone
-
Address
-
Compare NNNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
49.86 | 2.27B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Anbio Biotechnology Stock (NNNN) Latest News
Can machine learning forecast TMUS recoveryEarnings Beat & Technical Buy Zone Confirmation - Newser
News impact scoring models applied to Cmb.Tech NVWall Street Watch & Daily Profit Focused Screening - Newser
How to read the order book for STRRPMarket Movers & Real-Time Chart Breakout Alerts - Newser
Leading vs lagging indicators on ETI.PR performanceFed Meeting & High Accuracy Swing Entry Alerts - Newser
The Unlocking of Voting Control in Anbio Biotechnology: A Post-Lock-Up Opportunity in a Dual-Class IPO - AInvest
Anbio Biotechnology's Post-Lock-Up Investment Implications: Unlocking Shareholder Value and Market Dynamics - AInvest
Anbio Biotechnology Class A Ordinary Shares Subject to Lock-Up Agreement Ending August 18, 2025. - AInvest
Certain Class B Ordinary Shares of Anbio Biotechnology are subject to a Lock-Up Agreement Ending on 18-AUG-2025. - MarketScreener
Can MNTK expand its profit marginsMarket Trend Review & AI Forecasted Stock Moves - thegnnews.com
Will Aquestive Therapeutics Inc. price bounce be sustainablePortfolio Growth Summary & High Accuracy Swing Entry Alerts - Newser
CompanyInsider Selling & Reliable Breakout Stock Forecasts - Newser
Zhengye Skyrocketed 33.84%—What’s Fueling This Biotech Breakout? - AInvest
Will The Southern Company Preferred Security benefit from macro trendsMulti-Year Signal Summary and Entry Timing - Newser
enCore Energy Corp. stock prediction for this weekFree ROI Boosting Trade Opportunity Calendar - Newser
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System - digitalmore.co
Anbio Biotechnology's Strategic Expansion into Point-of-Care Diagnostics: A High-Growth Opportunity in Global Infectious Disease Management - AInvest
Breakthrough: Anbio's 15-Minute PCR System and Chikungunya Test Transform Disease Detection - Stock Titan
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System - GlobeNewswire Inc.
Why Coherus BioSciences Inc. stock attracts strong analyst attentionSummary of Trade Cycles in 5-Year Range - Newser
Full technical analysis of AFSC stockEarnings Based Stock Performance Forecast - Newser
Anbio Biotechnology (NNNN) Surges 13% in Dramatic Intraday Rally – What’s Fueling the Momentum? - AInvest
7 healthtech scaleups to watch in Europe & UK in 2025 - Tech Funding News
Is FORR stock bottoming outCapital Growth Plan for New Investors - Newser
Will Intuitive Machines Inc. stock recover after recent dropIntraday Movement Recap and Chart Summary - Newser
IRBT stock daily chart insightsDownside Control Plan With Support Analysis - Newser
Why UGRO stock attracts strong analyst attentionFree Early Entry Tips With Low Risk Zone - Newser
BAC.PRCC stock prediction for this weekFree Smart Money Tracking Signal Generator - Newser
Price momentum metrics for Iterum Therapeutics plc explainedEarly Entry Ideas with Momentum Potential - Newser
What Anbio Biotechnology's (NASDAQ:NNNN) ROE Can Tell Us - simplywall.st
Is a relief rally coming for BriaCell Therapeutics Corp. Equity Warrant holdersFree Stock Selection With High Accuracy - Newser
How to escape a deep drawdown in HTOOFree Pattern Breakout Entry Stock Forecast - Newser
Has ESLT formed a bullish divergenceFree Short Term Buy List With Stop Protection - Newser
Why CARGO Therapeutics Inc. stock attracts strong analyst attentionAI Trading Forecast Based on Big Data - Newser
What momentum shifts mean for C.PRGCSwing Reversal Forecast Based on Patterns - Newser
Is Enigmatig Limited stock bottoming outFree Trade Timing Strategy With Technical Data - Newser
How many analysts rate Anbio Biotechnology as a “Buy”Swing Trade Report For Consistent Profits - Jammu Links News
Risk vs reward if holding onto Anbio BiotechnologyEarnings Report Summary with Market Impact - Newser
Sentiment analysis tools applied to DHT Holdings Inc.Free Accurate Technical Trend Reversal Picks - Newser
What makes Anbio Biotechnology stock price move sharplyFree Fundamental Growth Stock Analysis - Newser
Using R and stats models for Otis Worldwide Corporation forecastingAlgorithmic Forecast for Swing Trading Picks - Newser
What catalysts could drive Anbio Biotechnology stock higher in 2025Top Growth Data Feed From AI Tools - Jammu Links News
What is Anbio Biotechnology company’s growth strategyPost Market Opportunities With High Returns - Jammu Links News
Applying sector rotation models to Signing Day Sports Inc.Free Access to Smart Investment Tips - Newser
Why Anbio Biotechnology stock attracts strong analyst attentionMomentum Screener with Buy and Sell Areas - Newser
Institutional scanner results for Anbio BiotechnologyDaily Exit and Entry Price Prediction - Newser
Alnylam Pharmaceuticals Skyrocketed 16.26%—Can This Biotech Breakout Sustain Momentum? - AInvest
Anbio Biotechnology's 15min chart sees KDJ Golden Cross and Bullish Marubozu - AInvest
Why Churchill Capital Corp IX stock attracts strong analyst attentionChart Confirmation Setup with ROI Signals - Newser
Using fundamentals and technicals on CDNSFree Daily Picks With Predictable Performance - Newser
Anbio Biotechnology Plunges 8.67%, What Storm Is Brewing in the Diagnostics Sector? - AInvest
Inmune Bio shares fall 2.53% premarket after announcing a video detailing MINDFuL trial findings. - AInvest
Anbio Biotechnology Stock (NNNN) Financials Data
There is no financial data for Anbio Biotechnology (NNNN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
6.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):